This morning, another 14 diabetes patients in California
filed suit in the Los Angeles Superior Court, bringing the count of Californiavictims filing suit to over 115. Nationwide, there have been over 1,000
lawsuits to date.
These complaints allege the manufacturer, Takeda
Pharmaceuticals, and their distributor, Eli Lily, “concealed and failed to
completely disclose their knowledge that Actos was associated with or could
cause bladder cancer or their knowledge that they had failed to fully study and
test regarding that risk and, further, made conscious decisions to ignore the
association between the use of Actos and pioglitazone hydrochloride and the risk
of developing bladder cancer.”
Many of these lawsuits, such as 5 new lawsuits filed in Los
Angeles Superior Court today, are wrongful death claims initiated by surviving
family members. Common claims are that a loved one took Actos for over a year
in order to control their type 2 or “lifestyle” diabetes and died of bladder
cancer while on the drug.
WHAT IS ACTOS' EFFECT?
Studies show that there is as much as a 40% increase in
getting bladder cancer after taking Actos for a year or longer. Due to these often repeated results, the U.S.
Food and Drug Administration (FDA) has issued a public health warning that
using this drug could increase your chances of getting bladder cancer. Thousands of patients claim to have been injured by Actos.
Over 20% of the diabetes medication prescribed today is
Actos. Since 2007, it is the most
commonly prescribed drug in the world for treating type-2 diabetes. In America alone, it is the 10th
most prescribed drug. That’s a lot of diabetics at risk for developing bladder
cancer.
Injured patients have been filing suit across the United
States seeking relief for their injuries.
If you’ve developed bladder cancer after taking Actos, you may be
entitled to compensation. Consult a
trusted attorney today to discuss your rights.
